Ipca Laboratories, 524494, IPCALAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

28,303.24
24.83
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

28,604.15
0.22%
6.02

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.30
10.01
12.34

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.11
26.61
15.04

PAT CAGR (%)

10 Years
5 Years
3 Years

8.86
44.84
36.03

P:E (Median)

8 Years
5 Years
3 Years

32.37
34.52
29.96

P:BV (Average)

8 Years
5 Years
3 Years

4.29
4.14
4.83

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.14
19.48
19.21

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 1,040.92 1,004.79 3.60% 1,315.22 1,139.07 15.46% 1,297.77 1,212.56 7.03% 1,485.25 1,011.01 46.91%
Expenses 824.28 812.07 1.50% 966.39 873.63 10.62% 937.61 951.00 -1.41% 897.30 815.97 9.97%
EBITDA 216.64 192.72 12.41% 348.83 265.44 31.42% 360.16 261.56 37.70% 587.95 195.04 201.45%
EBIDTM 20.81% 19.18% 26.52% 23.30% 27.75% 21.57% 39.59% 19.29%
Other Income 19.91 13.30 49.70% 15.65 17.63 -11.23% 15.00 14.33 4.68% 11.69 19.43 -39.84%
Interest 2.31 3.47 -33.43% 1.56 3.80 -58.95% 1.81 4.05 -55.31% 2.46 4.47 -44.97%
Depreciation 48.57 45.38 7.03% 47.66 46.16 3.25% 46.26 45.11 2.55% 45.23 42.04 7.59%
PBT 185.67 157.17 18.13% 315.26 233.11 35.24% 327.09 226.73 44.26% 551.94 167.96 228.61%
Tax 34.19 29.41 16.25% 55.29 36.48 51.56% 51.41 30.71 67.40% 98.30 35.91 173.74%
PAT 151.48 127.76 18.57% 259.97 196.63 32.21% 275.68 196.02 40.64% 453.64 132.05 243.54%
PATM 14.55% 12.72% 19.77% 17.26% 21.24% 16.17% 30.54% 13.06%
EPS 11.94 10.07 18.57% 20.49 15.49 32.28% 21.72 15.45 40.58% 35.75 10.41 243.42%

Description Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var%
Net Sales 1,114.66 1,073.76 3.81% 1,409.83 1,212.86 16.24% 1,361.10 1,283.90 6.01% 1,534.40 1,078.19 42.31%
Expenses 885.75 905.30 -2.16% 1,042.90 939.20 11.04% 1,000.91 1,018.04 -1.68% 946.08 879.47 7.57%
EBITDA 228.91 168.46 35.88% 366.93 273.66 34.08% 360.19 265.86 35.48% 588.32 198.72 196.05%
EBIDTM 20.54% 15.69% 26.03% 22.56% 26.46% 20.71% 38.34% 18.43%
Other Income 19.92 13.73 45.08% 15.38 18.13 -15.17% 15.45 14.80 4.39% 12.09 20.34 -40.56%
Interest 1.70 3.67 -53.68% 2.29 4.01 -42.89% 2.31 4.23 -45.39% 2.74 4.59 -40.31%
Depreciation 52.50 63.94 -17.89% 53.52 50.83 5.29% 52.12 49.63 5.02% 51.03 46.10 10.69%
PBT 194.63 114.58 69.86% 326.50 236.95 37.79% 321.21 226.80 41.63% 546.64 168.37 224.67%
Tax 30.93 29.20 5.92% 56.73 36.89 53.78% 52.59 31.89 64.91% 99.89 37.35 167.44%
PAT 163.70 85.38 91.73% 269.77 200.06 34.84% 268.62 194.91 37.82% 446.75 131.02 240.98%
PATM 14.69% 7.95% 19.13% 16.49% 19.74% 15.18% 29.12% 12.15%
EPS 12.72 6.81 86.78% 20.93 15.64 33.82% 21.05 15.28 37.76% 35.31 10.26 244.15%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 5,139.16 4,337.82 3,605.66 3,193.40 3,102.21 2,843.06 3,087.84 3,234.82 2,771.24 2,326.60 1,879.18 Net Sales Growth 17.67% 20.31% 12.91% 2.94% 9.12% -7.93% -4.54% 16.73% 19.11% 23.81% Cost Of Goods Sold 1,582.48 1,292.23 1,010.36 966.04 936.63 891.24 956.40 953.85 949.52 795.06 671.67 Gross Profit 3,556.68 3,045.59 2,595.30 2,227.36 2,165.58 1,951.82 2,131.44 2,280.97 1,821.72 1,531.54 1,207.51 GP Margin 69.21% 70.21% 71.98% 69.75% 69.81% 68.65% 69.03% 70.51% 65.74% 65.83% 64.26% Total Expenditure 3,625.58 3,439.48 2,926.87 2,766.48 2,703.54 2,585.54 2,582.48 2,528.38 2,236.09 1,899.28 1,537.94 Power & Fuel Cost - 196.82 175.25 159.89 148.93 140.03 133.39 125.94 103.36 82.94 58.95 % Of Sales - 4.54% 4.86% 5.01% 4.80% 4.93% 4.32% 3.89% 3.73% 3.56% 3.14% Employee Cost - 870.79 752.24 712.78 674.93 603.35 541.22 477.86 376.57 322.20 261.59 % Of Sales - 20.07% 20.86% 22.32% 21.76% 21.22% 17.53% 14.77% 13.59% 13.85% 13.92% Manufacturing Exp. - 449.83 363.05 359.41 400.11 380.86 437.27 412.77 328.81 273.66 238.04 % Of Sales - 10.37% 10.07% 11.25% 12.90% 13.40% 14.16% 12.76% 11.87% 11.76% 12.67% General & Admin Exp. - 233.95 261.02 262.26 237.93 277.90 239.23 245.82 196.76 169.91 132.35 % Of Sales - 5.39% 7.24% 8.21% 7.67% 9.77% 7.75% 7.60% 7.10% 7.30% 7.04% Selling & Distn. Exp. - 355.23 317.80 275.05 281.33 226.94 248.38 234.50 213.47 197.27 170.96 % Of Sales - 8.19% 8.81% 8.61% 9.07% 7.98% 8.04% 7.25% 7.70% 8.48% 9.10% Miscellaneous Exp. - 40.63 47.15 31.05 23.68 65.22 26.59 77.64 67.60 58.24 170.96 % Of Sales - 0.94% 1.31% 0.97% 0.76% 2.29% 0.86% 2.40% 2.44% 2.50% 0.23% EBITDA 1,513.58 898.34 678.79 426.92 398.67 257.52 505.36 706.44 535.15 427.32 341.24 EBITDA Margin 29.45% 20.71% 18.83% 13.37% 12.85% 9.06% 16.37% 21.84% 19.31% 18.37% 18.16% Other Income 62.25 84.16 71.57 57.70 56.52 46.27 58.65 51.14 44.23 49.16 89.03 Interest 8.14 18.84 21.09 27.46 25.99 31.11 29.11 27.60 34.01 42.23 31.14 Depreciation 187.72 178.69 171.88 174.36 171.00 161.23 177.17 100.89 84.00 65.31 55.43 PBT 1,379.96 784.97 557.39 282.80 258.20 111.45 357.73 629.09 461.37 368.94 343.70 Tax 239.19 132.51 102.48 49.69 69.91 18.93 101.62 151.72 129.98 88.77 78.37 Tax Rate 17.33% 16.88% 18.39% 17.57% 27.08% 16.99% 28.41% 24.12% 28.17% 24.06% 23.48% PAT 1,140.77 652.46 454.91 233.11 188.29 92.52 256.11 477.37 331.39 280.17 255.37 PAT before Minority Interest 1,140.77 652.46 454.91 233.11 188.29 92.52 256.11 477.37 331.39 280.17 255.37 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 22.20% 15.04% 12.62% 7.30% 6.07% 3.25% 8.29% 14.76% 11.96% 12.04% 13.59% PAT Growth 74.84% 43.43% 95.15% 23.80% 103.51% -63.87% -46.35% 44.05% 18.28% 9.71% EPS 89.90 51.42 35.85 18.37 14.84 7.29 20.18 37.62 26.11 22.08 20.12

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 5,419.99 4,619.03 3,745.69 3,257.76 3,156.19 2,867.11 3,144.40 3,281.77 2,805.94 2,355.96 1,897.88 Net Sales Growth 16.59% 23.32% 14.98% 3.22% 10.08% -8.82% -4.19% 16.96% 19.10% 24.14% Cost Of Goods Sold 1,728.30 1,455.41 1,090.34 978.34 939.40 903.04 968.00 963.06 955.10 800.91 680.51 Gross Profit 3,691.69 3,163.62 2,655.35 2,279.42 2,216.79 1,964.07 2,176.40 2,318.71 1,850.84 1,555.05 1,217.37 GP Margin 68.11% 68.49% 70.89% 69.97% 70.24% 68.50% 69.22% 70.65% 65.96% 66.00% 64.14% Total Expenditure 3,875.64 3,728.56 3,067.42 2,815.78 2,740.77 2,593.42 2,630.33 2,569.79 2,268.34 1,928.47 1,558.05 Power & Fuel Cost - 201.22 176.50 161.92 151.00 141.67 135.94 127.91 104.79 83.78 59.18 % Of Sales - 4.36% 4.71% 4.97% 4.78% 4.94% 4.32% 3.90% 3.73% 3.56% 3.12% Employee Cost - 921.23 787.40 735.88 695.98 625.58 566.70 497.99 391.79 335.49 266.28 % Of Sales - 19.94% 21.02% 22.59% 22.05% 21.82% 18.02% 15.17% 13.96% 14.24% 14.03% Manufacturing Exp. - 471.80 374.26 366.92 404.52 387.75 439.11 415.69 331.73 275.82 238.31 % Of Sales - 10.21% 9.99% 11.26% 12.82% 13.52% 13.96% 12.67% 11.82% 11.71% 12.56% General & Admin Exp. - 249.90 271.85 268.52 246.68 245.42 246.73 255.40 205.02 178.12 139.13 % Of Sales - 5.41% 7.26% 8.24% 7.82% 8.56% 7.85% 7.78% 7.31% 7.56% 7.33% Selling & Distn. Exp. - 359.15 317.84 277.62 280.74 223.67 245.00 231.18 212.94 196.09 169.91 % Of Sales - 7.78% 8.49% 8.52% 8.89% 7.80% 7.79% 7.04% 7.59% 8.32% 8.95% Miscellaneous Exp. - 69.85 49.23 26.58 22.45 66.29 28.85 78.56 66.97 58.26 169.91 % Of Sales - 1.51% 1.31% 0.82% 0.71% 2.31% 0.92% 2.39% 2.39% 2.47% 0.25% EBITDA 1,544.35 890.47 678.27 441.98 415.42 273.69 514.07 711.98 537.60 427.49 339.83 EBITDA Margin 28.49% 19.28% 18.11% 13.57% 13.16% 9.55% 16.35% 21.69% 19.16% 18.15% 17.91% Other Income 62.84 86.50 74.66 58.08 54.76 40.77 58.69 51.97 39.88 48.34 89.00 Interest 9.04 19.77 22.24 27.57 26.91 34.56 32.13 30.23 36.48 44.39 32.35 Depreciation 209.17 210.50 182.42 177.73 172.95 163.26 179.55 103.13 86.73 67.13 55.79 PBT 1,388.98 746.70 548.27 294.76 270.32 116.64 361.08 630.59 454.27 364.31 340.69 Tax 240.14 135.33 104.24 51.11 67.52 20.44 101.93 152.39 129.94 88.11 78.38 Tax Rate 17.29% 18.12% 19.01% 17.34% 24.98% 17.52% 28.23% 24.17% 28.60% 24.19% 23.01% PAT 1,148.84 613.28 447.39 243.65 202.80 96.20 259.15 478.20 324.33 276.20 262.39 PAT before Minority Interest 1,147.71 611.37 444.03 243.65 202.80 96.20 259.15 478.20 324.33 276.20 262.31 Minority Interest -1.13 1.91 3.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.08 PAT Margin 21.20% 13.28% 11.94% 7.48% 6.43% 3.36% 8.24% 14.57% 11.56% 11.72% 13.83% PAT Growth 87.91% 37.08% 83.62% 20.14% 110.81% -62.88% -45.81% 47.44% 17.43% 5.26% EPS 90.53 48.33 35.26 19.20 15.98 7.58 20.42 37.68 25.56 21.77 20.68

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 3,677.54 3,136.66 2,694.94 2,475.12 2,283.05 2,233.33 1,981.61 1,569.85 1,262.27 1,053.86 Share Capital 25.27 25.27 25.24 25.24 25.24 25.24 25.24 25.24 25.17 25.14 Total Reserves 3,640.33 3,111.39 2,669.38 2,449.88 2,257.81 2,208.09 1,956.37 1,544.61 1,236.96 1,028.24 Non-Current Liabilities 265.43 307.04 420.11 546.49 661.70 696.75 456.21 509.21 432.58 282.35 Secured Loans 64.21 133.94 234.01 347.22 433.63 447.65 292.12 366.21 330.18 194.62 Unsecured Loans 14.17 0.00 0.00 4.52 50.65 53.75 0.00 0.00 0.00 0.00 Long Term Provisions 30.98 25.28 25.88 24.55 20.22 17.91 14.49 12.21 8.72 5.34 Current Liabilities 1,241.60 1,013.84 992.65 946.34 959.88 894.16 779.55 629.69 635.20 576.95 Trade Payables 537.85 464.09 414.75 388.06 415.24 302.56 337.05 265.46 230.71 177.05 Other Current Liabilities 294.88 266.94 262.00 315.35 296.09 234.93 249.82 165.18 174.56 99.89 Short Term Borrowings 309.27 195.86 239.04 177.30 182.86 320.98 137.96 157.14 201.36 263.35 Short Term Provisions 99.60 86.95 76.86 65.63 65.69 35.69 54.72 41.91 28.57 36.66 Total Liabilities 5,184.57 4,457.54 4,107.70 3,967.95 3,904.63 3,824.24 3,217.37 2,708.75 2,330.05 1,913.16 Net Block 1,840.97 1,740.10 1,854.61 1,945.97 1,976.58 1,752.96 1,306.11 1,075.33 912.82 697.82 Gross Block 2,679.08 2,412.97 2,358.72 2,276.99 2,137.32 2,465.90 1,851.29 1,524.85 1,284.51 985.58 Accumulated Depreciation 838.11 672.87 504.11 331.02 160.74 712.94 545.18 449.52 371.69 287.76 Non Current Assets 2,472.46 2,171.99 2,200.54 2,256.30 2,304.86 2,230.93 1,634.73 1,323.95 1,133.47 881.28 Capital Work in Progress 84.19 65.96 73.23 94.87 128.93 266.95 164.90 129.17 94.51 94.75 Non Current Investment 410.47 231.86 146.28 98.01 97.43 81.86 28.75 21.79 42.65 48.79 Long Term Loans & Adv. 123.30 128.11 115.80 103.53 79.61 118.33 125.12 87.77 76.13 36.98 Other Non Current Assets 13.53 5.96 10.62 13.92 22.31 10.83 9.85 9.89 7.36 2.94 Current Assets 2,712.11 2,285.55 1,907.16 1,711.65 1,599.77 1,593.31 1,582.64 1,384.80 1,196.58 1,031.88 Current Investments 238.25 90.38 69.35 113.57 0.00 0.00 0.15 0.15 0.15 0.15 Inventories 1,266.96 1,055.55 873.17 873.54 831.93 916.98 838.30 733.34 663.98 462.51 Sundry Debtors 839.13 632.06 594.38 501.98 441.45 353.55 448.76 415.93 340.91 369.87 Cash & Bank 152.40 259.81 131.03 17.53 161.98 113.19 69.22 54.66 9.25 8.44 Other Current Assets 215.37 218.35 225.55 189.43 164.41 209.59 226.21 180.72 182.29 190.91 Short Term Loans & Adv. 22.52 29.40 13.68 15.60 19.72 37.03 53.58 40.26 27.41 55.84 Net Current Assets 1,470.51 1,271.71 914.51 765.31 639.89 699.15 803.09 755.11 561.38 454.93 Total Assets 5,184.57 4,457.54 4,107.70 3,967.95 3,904.63 3,824.24 3,217.37 2,708.75 2,330.05 1,913.16

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 3,627.48 3,122.39 2,688.57 2,455.26 2,259.19 2,208.43 1,959.66 1,553.78 1,254.01 1,051.59 Share Capital 25.27 25.27 25.24 25.24 25.24 25.24 25.24 25.24 25.17 25.14 Total Reserves 3,590.27 3,097.12 2,663.01 2,430.02 2,233.95 2,183.19 1,934.42 1,528.54 1,228.70 1,025.97 Non-Current Liabilities 290.29 313.40 419.42 548.32 662.57 699.57 459.45 509.52 433.15 282.35 Secured Loans 88.80 133.94 234.01 347.22 433.63 447.65 292.12 366.21 330.18 194.62 Unsecured Loans 14.17 6.91 0.00 4.52 50.64 55.56 1.88 0.00 0.00 0.00 Long Term Provisions 32.23 25.28 25.88 24.55 20.22 18.03 14.93 12.21 8.72 5.34 Current Liabilities 1,326.42 1,097.50 1,007.57 955.93 969.95 904.36 791.45 633.65 640.17 578.53 Trade Payables 609.85 524.32 423.47 396.54 421.11 306.59 340.99 268.37 234.52 178.55 Other Current Liabilities 304.57 274.74 266.75 316.41 297.50 236.44 250.88 166.00 175.33 99.97 Short Term Borrowings 310.95 209.69 239.04 177.30 184.85 325.35 143.94 157.14 201.36 263.35 Short Term Provisions 101.05 88.75 78.31 65.68 66.49 35.98 55.64 42.14 28.96 36.66 Total Liabilities 5,257.82 4,548.83 4,115.56 3,959.51 3,891.71 3,812.36 3,210.56 2,696.95 2,327.33 1,911.81 Net Block 2,106.79 1,940.38 1,952.96 1,983.27 2,014.18 1,800.43 1,353.59 1,104.23 944.08 699.22 Gross Block 3,033.79 2,632.86 2,464.33 2,318.22 2,176.95 2,546.33 1,932.05 1,579.07 1,338.55 988.42 Accumulated Depreciation 927.00 692.48 511.37 334.95 162.77 745.90 578.46 474.84 394.47 289.20 Non Current Assets 2,402.11 2,171.08 2,170.08 2,217.69 2,269.79 2,198.38 1,609.14 1,299.78 1,117.30 875.01 Capital Work in Progress 85.22 66.33 73.00 94.64 128.74 267.22 164.90 129.17 94.51 94.75 Non Current Investment 71.31 30.05 17.52 22.24 25.82 16.19 9.00 8.87 33.93 40.68 Long Term Loans & Adv. 124.68 128.36 115.83 103.58 78.44 103.47 71.26 47.49 37.12 37.07 Other Non Current Assets 14.11 5.96 10.77 13.96 22.61 11.07 10.39 10.02 7.66 3.29 Current Assets 2,855.71 2,377.75 1,945.48 1,741.82 1,621.92 1,613.98 1,601.42 1,397.17 1,210.03 1,036.80 Current Investments 238.25 90.38 69.35 113.57 0.00 0.00 0.15 0.15 0.15 0.15 Inventories 1,323.12 1,072.50 880.59 882.22 837.42 926.56 847.58 741.03 669.89 466.40 Sundry Debtors 895.20 681.51 602.27 500.16 445.87 353.00 449.79 417.81 344.88 367.21 Cash & Bank 180.92 282.30 150.57 35.85 175.54 124.79 76.01 58.24 12.16 10.36 Other Current Assets 218.22 221.21 228.26 194.46 163.09 209.63 227.89 179.94 182.95 192.68 Short Term Loans & Adv. 22.30 29.85 14.44 15.56 17.31 36.19 53.84 31.22 27.73 56.71 Net Current Assets 1,529.29 1,280.25 937.91 785.89 651.97 709.62 809.97 763.52 569.86 458.27 Total Assets 5,257.82 4,548.83 4,115.56 3,959.51 3,891.71 3,812.36 3,210.56 2,696.95 2,327.33 1,911.81

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 554.35 495.65 323.86 271.14 696.00 455.34 514.78 386.85 318.84 214.57 PBT 784.97 557.39 282.80 258.20 111.45 357.73 629.09 461.37 368.94 343.70 Adjustment 174.69 174.79 185.03 161.82 201.27 182.03 134.36 117.23 152.12 37.06 Changes in Working Capital -258.90 -128.87 -86.56 -94.56 412.34 -9.96 -118.48 -100.02 -122.32 -102.16 Cash after chg. in Working capital 700.76 603.31 381.27 325.46 725.06 529.80 644.97 478.58 398.74 278.60 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -146.41 -107.66 -57.41 -54.32 -29.06 -74.46 -130.19 -91.73 -79.90 -64.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -498.13 -122.98 -119.34 -145.55 -213.62 -685.71 -362.07 -260.92 -251.45 -198.84 Net Fixed Assets -284.34 -46.98 -60.09 -105.61 466.60 -716.66 -362.17 -275.00 -298.69 -163.58 Net Investments -326.48 -106.61 -4.05 -114.15 -15.57 -52.96 -6.96 20.86 6.14 0.48 Others 112.69 30.61 -55.20 74.21 -664.65 83.91 7.06 -6.78 41.10 -35.74 Cash from Financing Activity -132.59 -222.83 -130.43 -156.39 -414.16 254.99 -138.36 -80.63 -69.02 -16.80 Net Cash Inflow / Outflow -76.37 149.84 74.09 -30.80 68.22 24.62 14.35 45.30 -1.63 -1.07 Opening Cash & Equivalents 348.44 198.60 124.51 155.31 87.09 67.46 53.11 7.81 7.22 8.29 Closing Cash & Equivalent 272.07 348.44 198.60 124.51 155.31 92.08 67.46 53.11 7.81 7.22

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 564.27 501.03 341.13 281.91 708.65 455.29 522.29 388.77 353.84 214.20 PBT 738.89 546.46 290.53 262.06 116.64 361.08 630.59 454.27 364.31 340.69 Adjustment 241.29 187.36 192.51 174.86 211.11 187.91 139.92 126.16 156.99 39.13 Changes in Working Capital -263.69 -121.97 -84.44 -103.73 410.30 -18.68 -117.72 -100.10 -87.39 -101.25 Cash after chg. in Working capital 716.49 611.85 398.60 333.19 738.05 530.31 652.79 480.33 433.91 278.57 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -152.22 -110.82 -57.47 -51.28 -29.40 -75.02 -130.50 -91.56 -80.07 -64.37 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -509.65 -165.06 -135.40 -148.82 -218.33 -676.40 -369.01 -259.87 -285.90 -198.10 Net Fixed Assets -284.34 -46.98 -60.09 -105.61 466.60 -716.66 -362.17 -275.00 -298.69 -163.58 Net Investments -326.48 -106.61 -4.05 -114.15 -15.57 -52.96 -6.96 20.86 6.14 0.48 Others 101.17 -11.47 -71.26 70.94 -669.36 93.22 0.12 -5.73 6.65 -35.00 Cash from Financing Activity -130.46 -183.20 -130.41 -159.13 -461.51 250.54 -136.13 -82.93 -71.81 -17.75 Net Cash Inflow / Outflow -75.84 152.77 75.32 -26.04 28.81 29.43 17.15 45.97 -3.87 -1.65 Opening Cash & Equivalents 370.92 218.15 142.83 168.87 140.06 74.25 56.69 10.72 9.14 10.79 Closing Cash & Equivalent 295.39 370.92 218.15 142.83 168.87 103.68 74.25 56.69 10.72 9.14

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 290.11 248.25 213.52 196.13 180.91 176.97 157.02 124.39 100.29 83.80 ROA 13.53% 10.62% 5.77% 4.78% 2.39% 7.27% 16.11% 13.15% 13.21% 14.45% ROE 19.18% 15.60% 9.02% 7.91% 4.10% 12.15% 26.88% 23.40% 24.20% 26.51% ROCE 20.84% 16.76% 9.53% 8.97% 4.52% 13.48% 27.57% 24.46% 23.86% 25.05% Fixed Asset Turnover 1.72 1.52 1.39 1.43 1.24 1.45 1.94 2.00 2.07 2.03 Receivable days 61.48 61.61 62.15 54.52 51.03 46.94 48.31 49.28 55.23 73.41 Inventory Days 97.05 96.88 99.02 98.55 112.26 102.68 87.80 90.97 87.53 80.30 Payable days 47.09 49.40 50.05 51.96 52.98 39.18 36.44 31.15 30.32 25.40 Cash Conversion Cycle 111.44 109.09 111.12 101.10 110.31 110.44 99.66 109.10 112.44 128.31 Total Debt/Equity 0.12 0.14 0.23 0.29 0.38 0.42 0.30 0.39 0.48 0.50 Interest Cover 42.67 27.43 11.30 10.93 4.58 13.29 23.79 14.57 9.74 11.72

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 286.15 247.12 213.02 194.55 179.02 174.99 155.28 123.12 99.63 83.62 ROA 12.47% 10.25% 6.03% 5.17% 2.50% 7.38% 16.19% 12.91% 13.03% 14.88% ROE 18.15% 15.28% 9.47% 8.60% 4.31% 12.43% 27.22% 23.10% 23.97% 27.41% ROCE 19.92% 16.53% 9.94% 9.44% 4.82% 13.78% 27.92% 24.38% 23.78% 25.72% Fixed Asset Turnover 1.64 1.48 1.37 1.43 1.23 1.42 1.89 1.95 2.04 2.05 Receivable days 61.90 62.09 61.27 53.75 50.16 46.12 47.78 49.05 54.65 72.06 Inventory Days 94.05 94.47 97.98 97.70 110.76 101.93 87.49 90.74 87.21 80.79 Payable days 49.85 51.13 50.35 52.23 52.92 39.11 36.45 31.30 30.47 25.50 Cash Conversion Cycle 106.10 105.43 108.90 99.22 108.00 108.95 98.82 108.49 111.38 127.35 Total Debt/Equity 0.13 0.15 0.23 0.29 0.38 0.42 0.31 0.40 0.48 0.50 Interest Cover 38.77 25.65 11.69 11.05 4.38 12.24 21.86 13.45 9.21 11.53

Top Investors:

dsp midcap fund

hdfc trustee company ltd - a/c hdfc mid - capopportunities fund

l and t mutual fund trustee ltd-l and t mid cap fund

icici prudential pharma healthcare and diaganostics (p.h.d) fund

hdfc life insurance company limited

mirae asset emerging bluechip fund

uti flexi cap fund

axis mutual fund trustee limited a/c axis mutual fund a/c axis midcap fund

iepf

llp

Annual Reports:

News Update:

Ipca Laboratories acquires additional 13.09% stake in Trophic Wellness
11th Jun 2021, 16:29 PM

The Company now holds 52.35% of the paid-up equity share capital of TWPL
Read More

Ipca Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524494 | NSE: IPCALAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Ipca Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524494 | NSE: IPCALAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: